SARS-CoV-2-IN-15
SARS-CoV-2-IN-15 is a stabilized niclosamide analog with improved oral bioavailability and plasma half-life. This potent antiviral compound inhibits SARS-CoV-2 with an IC50 of 0.49 μM, making it a candidate for in vitro antiviral assays and in vivo efficacy studies against coronavirus infections.
Product Specifications
CAS Number
1580-42-3
Field of Research
Infectious Disease & Virology
Smiles
OC1=CC=C (Cl) C=C1C (=O) NC1=CC=CC (=C1) C (F) (F) F
Molecular Formula
C14H9ClF3NO2
Molecular Weight
315.67
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog